已收录 268921 条政策
 政策提纲
  • 暂无提纲
Effects of OKY-046, a Selective Thromboxane A2 Synthetase Inhibitor, on Ventricular Arrhythmias and Prostaglandins during Coronary Artery Ligation and Reperfusion in Anesthetized Dogs
[摘要] References(9)Cited-By(2)Effects of OKY-046, a selective thromboxane synthetase inhibitor, on ischemia-induced ventricular arrhythmias were investigated in anesthetized dogs. OKY-046 (30 mg/kg, intravenously) decreased ventricular arrhythmias significantly both during 30 min of coronary artery ligation and subsequent reperfusion, which corresponded with a significant reduction of thromboxane concentration, suggesting that thromboxane released during ligation is an important factor in the development of ventricular arrhythmias. Inhibition of thromboxane synthesis with OKY-046 might be useful for the prevention of ischemia-induced ventricular arrhythmias.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 药理学
[关键词]  [时效性] 
   浏览次数:2      统一登录查看全文      激活码登录查看全文